NEW YORK (GenomeWeb) – OpGen reported after the opening of the market on Wednesday an 18 percent increase in its fourth quarter revenues.

For the three months ended Dec. 31, the Gaithersburg, Maryland-based infectious disease testing and analysis firm reported $1.3 million in revenues, up from $1.1 million in the prior-year Q4.

Product sales increased 220 percent to $1.3 million, attributable to the firm's acquisition of AdvanDx in July.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.